论文部分内容阅读
目的评定生长抑素治疗急性重症胰腺炎患者临床治疗中配合展开护理干预方案的有效性。方法 83例急性重症胰腺炎患者,随机分成干预组(42例)和对照组(41例)。干预组实施生长抑素治疗+护理干预方案,对照组实施生长抑素治疗+常规护理方案。对比两组护理效果。结果干预组患者护理满意度调查中用药观察、用药效果、用药技术、心理指导水平评分均优于对照组(P<0.05);干预组有6例(14.29%)出现不良反应,其中1例腹胀,3例上腹异常疼痛,2例恶心呕吐;对照组有18例(43.90%)出现不良反应,其中3例腹胀,5例上腹异常疼痛,10例恶心呕吐;两组不良反应发生率比较差异有统计学意义(P<0.05)。结论在急性重症胰腺炎患者中,推行生长抑素治疗+护理干预方案效果显著,值得临床推广。
Objective To evaluate the effectiveness of somatostatin in the treatment of acute severe pancreatitis in clinical treatment with nursing intervention program. Methods 83 patients with acute severe pancreatitis were randomly divided into intervention group (n = 42) and control group (n = 41). The intervention group implemented the somatostatin treatment + nursing intervention program, the control group implemented the somatostatin treatment + routine nursing program. Compare two groups of nursing effects. Results In the intervention group, medication observation, medication effect, medication technique and psychological guidance level were all better than the control group (P <0.05). Six patients (14.29%) in the intervention group had adverse reactions, including 1 case of bloating , 3 cases of abnormal pain in upper abdomen and 2 cases of nausea and vomiting; 18 cases (43.90%) had adverse reactions in control group, including 3 cases of abdominal distension, 5 cases of abdominal pain and 10 cases of nausea and vomiting; The difference was statistically significant (P <0.05). Conclusion In patients with severe acute pancreatitis, the implementation of somatostatin treatment + nursing intervention program has a significant effect, worthy of clinical promotion.